BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33785171)

  • 21. Initiation and promotion of experimental oral mucosal carcinogenesis in mice.
    Steidler NE; Reade PC
    J Oral Pathol; 1986 Jan; 15(1):43-7. PubMed ID: 3080566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma.
    Ludwig S; Hong CS; Razzo BM; Fabian KPL; Chelvanambi M; Lang S; Storkus WJ; Whiteside TL
    Cancer Immunol Immunother; 2019 Jul; 68(7):1133-1141. PubMed ID: 31139925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial dysplasia and squamous cell carcinoma of the Wistar rat palatal mucosa: 4NQO model.
    Nauta JM; Roodenburg JL; Nikkels PG; Witjes MJ; Vermey A
    Head Neck; 1996; 18(5):441-9. PubMed ID: 8864735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of promotion activity of diacylglycerol oil on 4-nitroquinoline 1-oxide induced carcinogenesis in the oral cavity of SD rats.
    Umemura T; Maeda M; Kijima A; Ishii Y; Tasaki M; Okamura T; Inoue T; Hirose M; Nishikawa A
    Food Chem Toxicol; 2008 Sep; 46(9):3206-12. PubMed ID: 18694799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-nitroquinoline 1-oxide induces immune cells death to onset early immunosuppression during oral squamous cell carcinoma development.
    Sahu SR; Thakur S; Peroumal D; Utkalaja BG; Dutta A; Kumari P; Subhadarsini I; Acharya N
    Front Immunol; 2023; 14():1274519. PubMed ID: 37936711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response relationship in complete oral 4NQO-carcinogenesis in rats.
    Fisker AV; Philipsen HP; Overvad K
    Acta Pathol Microbiol Immunol Scand A; 1987 Sep; 95(5):281-8. PubMed ID: 3115060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Detection of Leukoplakic Oral Squamous Cell Carcinoma Using 4NQO-induced Rat Tongue Cancer Model: Study Utilizing Fluorescence Intensity and Histopathological Evaluation.
    Masuda H; Yamamoto N; Shibahara T
    Bull Tokyo Dent Coll; 2022 Mar; 63(1):1-12. PubMed ID: 35173082
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    García-Carracedo D; Cai Y; Qiu W; Saeki K; Friedman RA; Lee A; Li Y; Goldberg EM; Stratikopoulos EE; Parsons R; Lu C; Efstratiadis A; Philipone EM; Yoon AJ; Su GH
    Mol Cancer Res; 2020 Jun; 18(6):822-834. PubMed ID: 32152233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses.
    Shrotriya S; Tyagi A; Deep G; Orlicky DJ; Wisell J; Wang XJ; Sclafani RA; Agarwal R; Agarwal C
    Mol Carcinog; 2015 Apr; 54(4):291-300. PubMed ID: 24243690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma.
    Melis M; Zhang T; Scognamiglio T; Gudas LJ
    Carcinogenesis; 2020 Nov; 41(11):1553-1564. PubMed ID: 32115621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-adrenergic blocker inhibits oral carcinogenesis and reduces tumor invasion.
    Cecilio HP; Valente VB; Pereira KM; Kayahara GM; Furuse C; Biasoli ÉR; Miyahara GI; Oliveira SHP; Bernabé DG
    Cancer Chemother Pharmacol; 2020 Nov; 86(5):681-686. PubMed ID: 32980903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides.
    Hingorani DV; Lemieux AJ; Acevedo JR; Glasgow HL; Kedarisetty S; Whitney MA; Molinolo AA; Tsien RY; Nguyen QT
    Oral Oncol; 2017 Aug; 71():156-162. PubMed ID: 28688684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral mucosal carcinogenesis in SENCAR mice.
    Kim TW; Chen Q; Shen X; Regezi JA; Ramos DM; Tanaka H; Jordan RC; Kramer RH
    Anticancer Res; 2002; 22(5):2733-40. PubMed ID: 12529989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats.
    Khiavi MM; Abdal K; Abbasi MM; Hamishehkar H; Aghbali AA; Salehi R; Sina M; Abdollahi B; Fotohi S
    Indian J Med Res; 2017 Jan; 145(1):112-117. PubMed ID: 28574023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proposal of a secure and efficient protocol for a murine oral carcinogenesis model induced by 4-nitroquinoline-1-oxide (4NQO).
    Schuch LF; Campagnol D; Schmidt TR; Michel CHT; Garcez TNA; Danilevicz CK; Castilho RM; Martins MAT; Vargas PA; Martins MD
    Pathol Res Pract; 2023 Jul; 247():154547. PubMed ID: 37244052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination Treatment of TRPV4 Agonist with Cisplatin Promotes Vessel Normalization in an Animal Model of Oral Squamous Cell Carcinoma.
    Yahya F; Mohd Bakri M; Hossain MZ; Syed Abdul Rahman SN; Mohammed Alabsi A; Ramanathan A
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can propranolol act as a chemopreventive agent during oral carcinogenesis? An experimental animal study.
    Wagner VP; Spuldaro TR; Nör F; Gaio EJ; Castilho RM; Carrard VC; Rösing CK
    Eur J Cancer Prev; 2021 Jul; 30(4):315-321. PubMed ID: 33136608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
    de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ
    Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer.
    Young MR
    J Immunother; 2008; 31(2):148-56. PubMed ID: 18481384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the Blood Parameters, Cardiac and Liver Enzymes in Oral Squamous Cell Carcinoma Following Treated with Injectable Doxorubicin-Loaded Nano-Particles.
    Moradzadeh Khiavi M; Anvari E; Hamishehkar H; Abdal K
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):1973-1977. PubMed ID: 31350953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.